Altimmune ALT Stock
$3.27
-0.607902%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$636.07M
LOW - HIGH [24H]
$3.26
-
$3.41
VOLUME [24H]
$2.68M
P/E Ratio
0
Earnings per share
-$0.76
ISIN
US02155H2004
Altimmune Price Chart
Altimmune ALT Financial and Trading Overview
| Altimmune stock price | 3.27 USD |
| Previous Close | 3.29 USD |
| Open | 3.33 USD |
| Bid | 2.24 USD x 200 |
| Ask | 3.92 USD x 200 |
| Day's Range | 3.26 - 3.41 USD |
| 52 Week Range | 2.56 - 6.44 USD |
| Volume | 2.68M USD |
| Avg. Volume | 4.5M USD |
| Market Cap | 636.07M USD |
| Beta (5Y Monthly) | 0.176 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.76 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | January 20, 2017 |
| 1y Target Est | 17.22 USD |
ALT Valuation Measures
| Enterprise Value | 349.7M USD |
| Trailing P/E | N/A |
| Forward P/E | -4.892792 |
| PEG Ratio (5 yr expected) | 32.62 |
| Price/Sales (ttm) | 20518.479 |
| Price/Book (mrq) | 1.3412633 |
| Enterprise Value/Revenue | 11280.717 |
| Enterprise Value/EBITDA | -3.545 |
Trading Information
Altimmune Stock Price History
| Beta (5Y Monthly) | 0.176 |
| 52-Week Change | -9.61% |
| S&P500 52-Week Change | 15.30% |
| 52 Week High | 6.44 USD |
| 52 Week Low | 2.56 USD |
| 50-Day Moving Average | 3.04 USD |
| 200-Day Moving Average | 3.63 USD |
ALT Share Statistics
| Avg. Volume (3 month) | 4.5M USD |
| Avg. Daily Volume (10-Days) | 3.41M USD |
| Shares Outstanding | 194.52M |
| Float | 164.39M |
| Short Ratio | 11.28 |
| % Held by Insiders | 0.41% |
| % Held by Institutions | 77.76% |
| Shares Short | 49.71M |
| Short % of Float | 25.59% |
| Short % of Shares Outstanding | 25.55% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -318493.54% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -17.19% |
| Return on Equity (ttm) | -28.87% |
Income Statement
| Revenue (ttm) | 31K USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -66693000 USD |
| EBITDA | -98634000 USD |
| Net Income Avi to Common (ttm) | -91760000 USD |
| Diluted EPS (ttm) | -0.76 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 326.28M USD |
| Total Cash Per Share (mrq) | 1.68 USD |
| Total Debt (mrq) | 36.02M USD |
| Total Debt/Equity (mrq) | 7.6 USD |
| Current Ratio (mrq) | 26.783 |
| Book Value Per Share (mrq) | 2.438 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -76508000 USD |
| Levered Free Cash Flow (ttm) | -48786124 USD |
Profile of Altimmune
| Country | United States |
| State | MD |
| City | Gaithersburg |
| Address | 910 Clopper Road |
| ZIP | 20878 |
| Phone | 240 654 1450 |
| Website | https://altimmune.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 57 |
Altimmune, Inc., a late clinical stage biopharmaceutical company, focuses on developing novel therapies for serious liver diseases. Its lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist, which is in Phase 3 clinical trial for the treatment of metabolic dysfunction-associated steatohepatitis, alcohol use disorder, and alcohol-associated liver disease. The company was founded in 1997 and is headquartered in Gaithersburg, Maryland.
Q&A For Altimmune Stock
What is a current ALT stock price?
Altimmune ALT stock price today per share is 3.27 USD.
How to purchase Altimmune stock?
You can buy ALT shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Altimmune?
The stock symbol or ticker of Altimmune is ALT.
Which industry does the Altimmune company belong to?
The Altimmune industry is Biotechnology.
How many shares does Altimmune have in circulation?
The max supply of Altimmune shares is 194.52M.
What is Altimmune Price to Earnings Ratio (PE Ratio)?
Altimmune PE Ratio is now.
What was Altimmune earnings per share over the trailing 12 months (TTM)?
Altimmune EPS is -0.76 USD over the trailing 12 months.
Which sector does the Altimmune company belong to?
The Altimmune sector is Healthcare.
Altimmune ALT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26333.04 USD — |
+0.96
|
5.66B USD — | 26283.11 USD — | 26431.22 USD — | — - | 5.66B USD — |
|
US Tech Global Market Composite
NQGM
US
|
2216.35 USD — |
+0.48
|
— — | 2215.68 USD — | 2236.57 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
6924.69 USD — |
+0.05
|
— — | 6924.47 USD — | 7006.06 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1293.65 USD — |
+0.08
|
— — | 1293.64 USD — | 1310.12 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
4000.62 USD — |
-1.26
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
- {{ link.label }} {{link}}
